IMGT IMAGE GUIDED THERAPY
LIVE

Serial Number

90022437

Owner

IMGT CO, LTD.

Attorney

Yoon S. Ham

Filing Date

Jun 26, 2020

Add to watchlist:

No watchlists yet
View on USPTO

IMGT IMAGE GUIDED THERAPY Trademark

Serial Number: 90022437 • Registration: 6542241

IMGT IMAGE GUIDED THERAPY is a trademark filed by IMGT CO, LTD. on June 26, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

IMGT CO, LTD. (4 trademarks)

Bundang-gu, Seongnam-si
Gyeonggi-do 13605 , KR

Entity Type: 99

Trademark Details

Filing Date

June 26, 2020

Registration Date

November 2, 2021

Published for Opposition

August 17, 2021

Goods & Services

Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting peripheral nervous system; Enzymes for medical purposes; Pharmaceutical preparations acting on the central nervous system; Antibiotic preparations; Chemotherapeutics; Veterinary vaccines; Vaccines; Chemical reagents for medical or veterinary purposes; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of CNS disorders; Pharmaceutical preparations for the treatment of peripheral vascular or neurologic disease; Pharmaceutical preparations for the treatment of lesions; Pharmaceutical preparations for reliving pain; Pharmaceutical preparations for activating drug delivery; Nutraceuticals for use as a dietary supplement for promoting digestion; Anti-cancer preparations

Medical apparatus, namely, medical ultrasound apparatus; Medical apparatus, namely, ultrasound diagnostic apparatus; Medical instruments for use in general surgery; Medical apparatus for treating cancer; Medical apparatus for treating cancer by using ultrasound; Medical apparatus for treating CNS disorders; Medical apparatus for treating CNS disorders by using ultrasound; Medical apparatus for treating peripheral vascular or neurologic disease; Medical apparatus for treating peripheral vascular or neurologic disease by using ultrasound; Medical apparatus for treating dermatological disease by using ultrasound; Medical apparatus for treating dermatological disease; Medical apparatus for treatment of lesions; Medical apparatus for treatment of lesions through hyperthermia caused by using ultrasound; Medical apparatus for relieving pain; Medical apparatus for relieving pain by using ultrasound; Medical apparatus for activating drug delivery; Medical apparatus for activating drug delivery by using ultrasound; Syringes for medical purposes and for injections; Medical apparatus for detecting cancer; Dental instruments, namely, picks, burrs, mirrors, prophy angles, oral irrigators, crown and bridge removers; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Diagnostic apparatus for the detection of periodontal disease; Diagnostic apparatus for the detection of cancer; Medical diagnostic apparatus for detecting cancer; Injection device for pharmaceuticals; Syringes for medical purposes; Syringes for injection of medical substances; Hypodermic syringes

Drug discovery services; Biotechnology research; Biomedical research services; Laboratory research in the field of biology; Providing information on the subject of scientific research in the field of Biochemistry and biotechnology; Biological research; Bacteriological research; Pharmaceutical research and development; Research on the subject of pharmaceuticals; Clinical research in the field of medicines for detection and treatment of cancer; Conducting clinical trials for others in the field of medicines for detection and treatment of cancer; Medical research services; Scientific research for medical purposes in the field of cancer; Testing of pharmaceuticals; Testing of materials; Chemical research and analysis; Chemical research services

Filing History

REGISTERED-PRINCIPAL REGISTER
Nov 2, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 17, 2021 NPUB
PUBLISHED FOR OPPOSITION
Aug 17, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 28, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 12, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 15, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 15, 2021 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 7, 2021 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 22, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 22, 2021 GNSL
SUSPENSION LETTER WRITTEN
Mar 22, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 19, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 19, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 19, 2021 TROA
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Oct 2, 2020 CEPE
ASSIGNED TO LIE
Oct 2, 2020 ALIE
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Oct 2, 2020 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Oct 2, 2020 GEAP
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Oct 2, 2020 CPEA
ASSIGNED TO EXAMINER
Sep 29, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 24, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 23, 2020 NWOS
NEW APPLICATION ENTERED
Jun 30, 2020 NWAP